Found 32 matching trials
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
PHASE2This study is examining how well a dry powder inhaler (DPI) of albuterol me...
Location
Teva Clinical Study Site
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
N/AAsthma is a common, long-term disease that is caused by inflammation of the...
Location
University of California, San Diego
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
PHASE2The purpose of this study is to demonstrate the superior bronchodilator eff...
Location
620 South 20th Street, NHB 104
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
PHASE2This is a randomized, double-blind, single-dose, placebo-controlled, 5-peri...
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
PHASE1The primary objective of this study is to compare the pharmacokinetic (PK) ...
Location
Teva Investigational Site 10538
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
PHASE3To Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation...
Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects
PHASE1Study to assess the safety and tolerability of COMBIVENT® hydrofluoroalkane...
Location
Multiple Locations
Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma
NAThe purpose of this study is to assess whether acupuncture is effective in ...
Location
University Hospital of Gansu Traditional Chinese Medicine
Albuterol HFA MDI in Pediatric Participants With Asthma
PHASE3The primary objective of this study is to evaluate the chronic-dose and eff...
Location
Pediatric Care Medical Group, Inc.
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
PHASE3The primary objective of this study is to evaluate long-term safety and pat...
Location
1012.62.153 Boehringer Ingelheim Investigational Site